sufentanil has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Citro, R; Collura, D; D'Urso, L; Grassano, MT; Grosso, P; Guglielminotti, E; Guglielmotti, E; Macchiarulo, R; Muto, G; Rivalta, L; Valz, C | 1 |
1 other study(ies) available for sufentanil and Prostatic Neoplasms
Article | Year |
---|---|
Transrectal-HIFU as primary minimally-invasive option for localized prostate cancer. Is spinal anaesthesia cost-effective? A single centre experience in over 100 patients.
Topics: Adjuvants, Anesthesia; Aged; Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Italy; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Retrospective Studies; Subarachnoid Space; Sufentanil; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal | 2009 |